Mettler-Toledo International (NYSE:MTD) Price Target Cut to $670.00 by Analysts at UBS Group

Mettler-Toledo International (NYSE:MTD) had its price target reduced by UBS Group from $680.00 to $670.00 in a research report sent to investors on Friday morning, AnalystRatings.com reports. UBS Group currently has a sell rating on the medical instruments supplier’s stock.

Other analysts also recently issued reports about the company. Barclays decreased their price target on Mettler-Toledo International from $680.00 to $640.00 and set an underweight rating on the stock in a research note on Wednesday, October 9th. Zacks Investment Research downgraded Mettler-Toledo International from a hold rating to a sell rating and set a $760.00 price target on the stock. in a research note on Tuesday, November 5th. Bank of America decreased their price target on Mettler-Toledo International from $830.00 to $720.00 and set a neutral rating on the stock in a research note on Thursday, October 17th. Finally, ValuEngine downgraded Mettler-Toledo International from a hold rating to a sell rating in a research note on Wednesday, October 2nd. Five analysts have rated the stock with a sell rating and one has assigned a hold rating to the company. The stock currently has an average rating of Sell and a consensus target price of $697.50.

Shares of Mettler-Toledo International stock traded down $11.95 during trading on Friday, reaching $708.86. The company’s stock had a trading volume of 410,664 shares, compared to its average volume of 167,265. The company has a quick ratio of 0.98, a current ratio of 1.39 and a debt-to-equity ratio of 2.16. Mettler-Toledo International has a 12-month low of $500.74 and a 12-month high of $873.51. The company has a market capitalization of $17.58 billion, a P/E ratio of 34.88, a price-to-earnings-growth ratio of 2.33 and a beta of 1.37. The business has a 50 day moving average price of $694.04 and a 200-day moving average price of $734.92.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $5.77 earnings per share for the quarter, beating the Zacks’ consensus estimate of $5.71 by $0.06. Mettler-Toledo International had a return on equity of 98.65% and a net margin of 18.45%. The firm had revenue of $753.90 million for the quarter, compared to the consensus estimate of $751.34 million. During the same period in the previous year, the business earned $5.12 earnings per share. The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. Research analysts predict that Mettler-Toledo International will post 22.7 EPS for the current fiscal year.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. boosted its position in Mettler-Toledo International by 1.2% during the second quarter. Vanguard Group Inc. now owns 2,773,530 shares of the medical instruments supplier’s stock worth $2,329,765,000 after purchasing an additional 34,044 shares in the last quarter. BlackRock Inc. boosted its position in Mettler-Toledo International by 7.4% during the second quarter. BlackRock Inc. now owns 1,858,924 shares of the medical instruments supplier’s stock worth $1,561,497,000 after purchasing an additional 128,157 shares in the last quarter. WCM Investment Management LLC boosted its position in Mettler-Toledo International by 3.5% during the second quarter. WCM Investment Management LLC now owns 1,548,699 shares of the medical instruments supplier’s stock worth $1,300,908,000 after purchasing an additional 52,874 shares in the last quarter. Bank of New York Mellon Corp boosted its position in Mettler-Toledo International by 1.8% during the second quarter. Bank of New York Mellon Corp now owns 365,142 shares of the medical instruments supplier’s stock worth $306,720,000 after purchasing an additional 6,332 shares in the last quarter. Finally, Northern Trust Corp boosted its position in Mettler-Toledo International by 3.0% during the second quarter. Northern Trust Corp now owns 350,784 shares of the medical instruments supplier’s stock worth $294,658,000 after purchasing an additional 10,145 shares in the last quarter. Institutional investors own 97.18% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications.

See Also: Catch-Up Contributions

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit